# FDA Accepts Aquestive Therapeutics’ Anaphylm Application for Review

By Riza Dagoc

Canonical URL: https://www.tokenpost.com/news/regulation/32537
Published: 2026-10-15T13:45:21.000Z
Updated: 2026-10-15T13:45:21.000Z
Section: Regulation

> Anaphylm is an epinephrine sublingual film intended for emergency treatment of severe allergic reactions.

Aquestive Therapeutics announced Thursday, Oct. 15, that the U.S. Food and Drug Administration (FDA) accepted its resubmitted application for Anaphylm for review.

Anaphylm is an epinephrine formulation delivered as a sublingual film. It is designed for emergency treatment of severe allergic reactions.